FindTrial
Sign In

publication on intravenous dexamethasone 8mg in prolonging supraclavicular nerve block using isobaric bupivacaine in upperlimb surgeries

publication on intravenous dexamethasone in prolonging supraclavicular nerve block using isobaric bupivacaine in upperlimb surgeries - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098755
Enrollment
60
Registered
2025-12-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: PCS-

Interventions

Intervention1: Effect of intravenous dexamethasone in prolonging supraclavicular nerve block using isobaric bupivacaine in upperlimb surgeries: subjects will receive 30ml Local anaesthetic mixture wit

Sponsors

vinayaka mission medical college and hospital salem
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA grade I and II. 2. Age between 18-60 years. 3. All elective upper limb surgeries below shoulder

Exclusion criteria

Exclusion criteria: Patient refusal. Age less than 18 and more than 60 years . ASA grade 3 and 4. Severe hepatic or renal failure Infection at the site of injection Patient with known allergy to LA drugs Patients on chronic use of corticosteroids Patients with coagulation abnormalities. Patients with respiratory compromise

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of intravenous dexamethasone on the onset and duration of sensory and motor blockadeTimepoint: from zero hours of block till 24 hours of surgery—

Secondary

MeasureTime frame
To study hemodynamic profile, the duration of analgesia and to study blood glucose level.Timepoint: from zero hours of block till 24 hours of surgery—

Countries

India

Contacts

Public ContactDrkrishnappreya

vinayaka mission medical college and hospital ,salem

nimmu1335@gmail.com09487873738

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026